A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...

Family and friends of Rachel Simon of Hazlet are staging events to find a bone marrow donor who can help her fight off ...

Cancer patients may have an increased risk of developing second primary malignancies after immune checkpoint inhibitor therapy.

Cancer drugs' sexual toxicity warrants a "call to action" among oncologists to address the problem. ( Lancet Oncology) U.S.

Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukemia in people at high risk ...

Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in ...

SLS009 is associated with an improvement in survival among patients with relapsed/refractory acute myeloid leukemia.

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

2025 — Scientists have identified an innovative combination of treatment strategies that work collaboratively to effectively kill acute myeloid leukemia ... Novel Bone Marrow Transplant Can Cure ...

Our aim is to provide patients access to advanced treatment options while getting the best cancer care. In Acute Myeloid Leukemia (AML), the bone marrow makes abnormal myeloblasts (a type of white ...

The FDA previously granted breakthrough therapy designation to ziftomenib for relapsed/refractory NPM1-mutant AML.

Research from the University of Cambridge shows that metformin, a widely used and affordable diabetes drug, could prevent a ...